Article Details

Inebilizumab-Cdon Reduces Risk of IgG4-Related DIsease Flares By 87% In Adult Patients

Retrieved on: 2024-06-07 23:07:46

Tags for this article:

Click the tags to see associated articles and topics

Inebilizumab-Cdon Reduces Risk of IgG4-Related DIsease Flares By 87% In Adult Patients. View article details on hiswai:

Excerpt

Inebilizumab is a monoclonal antibody and is currently indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult ...

Article found on: www.pharmacytimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up